Rafael Holdings RFL
NYSE RFL
$1.48 +0.16 (+12.12%)
As of: Oct 1, 2026 · 3:24 PM EDT

Rafael Holdings (RFL) Equity Income (2017 - 2024)

Updated

Rafael Holdings' Equity Income came in at -$1.63 million for FY2024 (year ended Jul 31, 2024), compared with $203,000 in FY2023.

Analysis

Rafael Holdings (RFL) Equity Income (2017 - 2024) Analysis & Trends

Going back to FY2018, Rafael Holdings' Equity Income data covers 6 fiscal years.

  • The FY2024 figure represents the lowest annual Equity Income in data going back to FY2018.
  • Per Business Quant, earlier fiscal years put Equity Income at $203,000 in FY2023, -$575,000 in FY2022, $383,000 in FY2021 (+99.5%) and $192,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -10.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Rafael Holdings 68.10 Mn 73.52 Mn 163,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2024 -1.63 Mn
Oct 31, 2021 -575,000.00
Jul 31, 2021 95,000.00
Apr 30, 2021 96,000.00
Jan 31, 2021 96,000.00
Oct 31, 2020 96,000.00
Jul 31, 2020 139,000.00
Apr 30, 2020 53,000.00
Jan 31, 2019 103,000.00
Oct 31, 2018 -10,000.00
Apr 30, 2018 3,000.00
Jan 31, 2018 -3,000.00
Oct 31, 2017 -104,000.00
API Access

Rafael Holdings Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=RFL&period=max&api_key=YOUR_API_KEY